REQUEST A DEMO
Total
USD $0.00
Search more companies

Lietuvos Ir Suomijos UAB Plandent (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Lietuvos Ir Suomijos UAB Plandent Profile Updated: January 01, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Lietuvos Ir Suomijos UAB Plandent is a company in Lithuania, with a head office in Kaunas. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on January 30, 1995. Lietuvos Ir Suomijos UAB Plandent currently employs 19 (2025) people. In 2025, the company reported a net sales revenue increase of 31.55%. Lietuvos Ir Suomijos UAB Plandent’s net profit margin decreased by 0.8% in 2025.

Headquarters
Partizanu g. 26B
Kaunas; Kaunas County; Postal Code: LT-50217

Contact Details: Purchase the Lietuvos Ir Suomijos UAB Plandent report to view the information.

Basic Information
Total Employees:
Purchase the Lietuvos Ir Suomijos UAB Plandent report to view the information.
Registered Capital:
Purchase the Lietuvos Ir Suomijos UAB Plandent report to view the information.
Financial Auditors:
Purchase the Lietuvos Ir Suomijos UAB Plandent report to view the information.
Incorporation Date:
January 30, 1995
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Lietuvos Ir Suomijos UAB Plandent report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
31.55%
Total operating revenue
31.55%
Net Profit/Loss for the Period
-29.04%
Total Equity
-2.87%
Net Profit Margin
-0.8%
Return on Equity (ROE)
-2.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?